Barni S - Search Results

1

5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.

Barni S, Visini M, Piazza E, Ionta MT, Ardizzoia A, Arnoldi E, Fava S, Pinotti G, Torretta F, Corradini G, Villa S, Nosenzo AM, Massidda B, Cazzaniga ME. Barni S, et al. Anticancer Res. 2007 Jul-Aug;27(4C):3019-24. Anticancer Res. 2007. PMID: 17695490 Free article. Clinical Trial.

2

Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-up.

Barni S, Piazza E, Frontini L, Visini M, Ardizzoia A, Grassi MM, Nosenzo MA, Mandalà M, Biasioli R, Freddi E, Lucani L, Recalcati A, Pravettoni A, Sala R, Rezzani C, Villa S, Trabucchi E; Neo-Adjuvant Breast Italian Group. Barni S, et al. Oncology. 2004;67(1):40-7. doi: 10.1159/000080284. Oncology. 2004. PMID: 15459494 Clinical Trial.

3

Vinorelbine as single agent in pretreated patients with advanced breast cancer.

Barni S, Ardizzoia A, Bernardo G, Villa S, Strada MR, Cazzaniga M, Archili C, Frontini L. Barni S, et al. Tumori. 1994 Aug 31;80(4):280-2. doi: 10.1177/030089169408000407. Tumori. 1994. PMID: 7974798 Clinical Trial.

4

Tamoxifen-induced sexual dysfunction in a breast cancer patient: a case report.

Barni S, Ardizzoia A. Barni S, et al. Tumori. 1998 May-Jun;84(3):417-8. doi: 10.1177/030089169808400321. Tumori. 1998. PMID: 9678629 No abstract available.

5

Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer.

Clerici M, De Marinis F, Piazza E, Frontini L, Tucci E, Barni S, Bretti S, Luporini G, Intini C. Clerici M, et al. Among authors: barni s. Tumori. 1998 Nov-Dec;84(6):669-72. doi: 10.1177/030089169808400611. Tumori. 1998. PMID: 10080674 Clinical Trial.

6

Vinorelbine and carboplatin in inoperable non-small cell lung cancer: a monoinstitutional phase II study.

Cremonesi M, Mandalà M, Cazzaniga M, Rezzani C, Gambera M, Barni S. Cremonesi M, et al. Among authors: barni s. Oncology. 2003;64(2):97-101. doi: 10.1159/000067765. Oncology. 2003. PMID: 12566905 Clinical Trial.

7

From the trastuzumab era to new target therapies: beyond revolution.

Barni S, Petrelli F, Cabiddu M, Cazzaniga ME, Cremonesi M. Barni S, et al. Ann Oncol. 2007 Jun;18 Suppl 6:vi1-4. doi: 10.1093/annonc/mdm214. Ann Oncol. 2007. PMID: 17591799 Free article. Review. No abstract available.

8

Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study.

Cazzaniga ME, Dogliotti L, Cascinu S, Barni S, Labianca R, Chiara S, Conte PF, Gasparini G, Pasetto L, Torri V. Cazzaniga ME, et al. Among authors: barni s. Oncology. 2006;71(5-6):374-81. doi: 10.1159/000107772. Epub 2007 Sep 3. Oncology. 2006. PMID: 17785994 Clinical Trial.

9

Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretion.

Lissoni P, Barni S, Cazzaniga M, Ardizzoia A, Rovelli F, Tancini G, Brivio F, Frigerio F. Lissoni P, et al. Among authors: barni s. Oncology. 1995 Nov-Dec;52(6):439-42. doi: 10.1159/000227507. Oncology. 1995. PMID: 7478427

10

Weekly epirubicin plus low-dose interleukin-2 subcutaneous therapy in breast cancer: preliminary immunobiological results.

Lissoni P, Barni S, Ardizzoia A, Fossati V, Paolorossi F, Tancini G. Lissoni P, et al. Among authors: barni s. J Biol Regul Homeost Agents. 1994 Apr-Jun;8(2):53-5. J Biol Regul Homeost Agents. 1994. PMID: 7863813 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

832 results

Search Page

Filters